Clinical Trials Browser

Phase 2/3 × anamorelin × 1 year × Clear all

NCT03637816 2025-11-03

Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer

Phase 2/3 Active not recruiting

Anorexia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms